Klaria Pharma Holding AB Logo

Klaria Pharma Holding AB

Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.

KLAR | ST

Overview

Corporate Details

ISIN(s):
SE0007280326
LEI:
529900YLMSNHNP7HOD11
Country:
Sweden
Address:
Virdings Allé 2, 754 50 UPPSALA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Klaria Pharma Holding AB is a pharmaceutical company that develops novel drug products based on its patented, proprietary alginate-based oral transmucosal film technology. This platform delivers active pharmaceutical ingredients directly into the bloodstream by adhering to the inside of the cheek, providing a non-invasive alternative to treatments currently available only as injections or nasal sprays. The company's strategy focuses on addressing significant patient needs where its technology offers clear advantages, such as improved convenience, safety, and efficacy. Klaria's development pipeline includes treatments for migraine (Sumatriptan), severe allergic reactions (Epinephrine), and organ transplant rejection (Sirolimus). The company also operates a subsidiary, Cannabis Delivery Sciences, which applies the film technology to cannabinoid-based products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Klaria Pharma Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Klaria Pharma Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mezzion Pharma Co., Ltd. Logo
Develops and out-licenses novel therapeutics like udenafil, with a focus on rare diseases.
South Korea 140410
MFC Co., Ltd. Logo
A GMP-certified CDMO/CMO developing and manufacturing APIs for the global pharma sector.
South Korea 432980
Mithra Pharmaceuticals S.A. Logo
Biotech firm developing pharma for women's health: contraception, fertility, and menopause.
Belgium MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.
Japan 4595
MOA Life Plus Co. Ltd. Logo
Develops immunotherapies & consumer solutions for immunity, skin rejuvenation, and pet care.
South Korea 142760
Moberg Pharma Logo
Develops & commercializes a leading topical treatment for nail fungus for European markets.
Sweden MOB
Mochida Pharmaceutical Co.,Ltd. Logo
An R&D-driven company making drugs, skincare, and medical equipment for specialized fields.
Japan 4534
Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.
South Korea 322970
MORISHITA JINTAN CO.,LTD. Logo
Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.
Japan 4524
MUROMACHI CHEMICALS INC. Logo
A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.
Japan 4885

Talk to a Data Expert

Have a question? We'll get back to you promptly.